- Home
- BMRN vs SNEX Comparison
BMRN vs SNEX Comparison
Compare BMRN & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | SNEX |
|---|---|---|
| Founded | 1996 | 1924 |
| Country | United States | United States |
| Employees | N/A | 5400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 9.1B |
| IPO Year | 1999 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BMRN | SNEX |
|---|---|---|
| Price | $67.45 | $66.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $88.22 | $81.33 |
| AVG Volume (30 Days) | ★ 2.1M | 1.0M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.77 | ★ 3.49 |
| Revenue | $1,313,646,000.00 | ★ $132,378,200,000.00 |
| Revenue This Year | $15.02 | N/A |
| Revenue Next Year | $12.23 | $4.17 |
| P/E Ratio | $88.99 | ★ $19.10 |
| Revenue Growth | 17.62 | ★ 32.53 |
| 52 Week Low | $49.26 | $63.33 |
| 52 Week High | $70.98 | $141.99 |
Technical Indicators
Market Signals| Indicator | BMRN | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 30.71 |
| Support Level | $58.03 | $63.33 |
| Resistance Level | N/A | $79.35 |
| Average True Range (ATR) | 2.13 | 3.43 |
| MACD | 0.74 | 0.85 |
| Stochastic Oscillator | 70.72 | 20.29 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About SNEX StoneX Group Inc.
StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.